Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PARP1 | P09874 | 1/20 | 0.56 |
| ▸ | FBP1 | P09467 | 9/20 | 0.51 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | CDK4 | P11802 | 2/20 | 0.44 |
| ▸ | CCND1 | P24385 | 2/20 | 0.44 |
| ▸ | GUSB | P08236 | 1/20 | 0.40 |
| ▸ | FEN1 | P39748 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26164146 | 0.93 | PARP1 (0.63) | PARP1FBP1TDP1ALDH1A1MAPT | |
| SCHEMBL26164175 | 0.91 | PARP1 (0.52) | PARP1FBP1TDP1ALDH1A1MAPT | |
| SCHEMBL26164176 | 0.90 | CDK4 (0.52) | PARP1FBP1TDP1ALDH1A1MAPT | |
| SCHEMBL26164171 | 0.88 | PARP1 (0.55) | PARP1FBP1TDP1ALDH1A1MAPT | |
| SCHEMBL26167531 | 0.87 | PARP1 (0.48) | PARP1FBP1TDP1ALDH1A1MAPT | |
| SCHEMBL26164184 | 0.86 | PARP1 (0.58) | PARP1FBP1TDP1ALDH1A1MAPT | |
| SCHEMBL26167533 | 0.82 | PARP1 (0.43) | PARP1FBP1TDP1ALDH1A1MAPT | |
| SCHEMBL21709358 | 0.78 | CDK4 (0.56) | PARP1ALDH1A1MAPK1CDK4CCND1 | |
| SCHEMBL26164179 | 0.76 | CDK4 (0.49) | PARP1TDP1ALDH1A1MAPTCDK4 | |
| SCHEMBL19893738 | 0.74 | FEN1 (0.56) | PARP1ALDH1A1MAPK1CDK4CCND1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230167145-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-06-01 | — | — | US | disclosed |
| US-20230167145-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-06-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230167145-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OCIAD1, OCIAD2, OSBP | PARP1 2010/4885FBP1 3455/4885TDP1 1863/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.